Nectar Lifescience Ltd share price logo

Nectar Lifescience Ltd (NECLIFE)

₹28.591.75%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹28.49
    ₹29.35
  • 52 Week's Low

    52 Week's High

    ₹21.25
    ₹45.7
1 Month Return-14.79 %
3 Month Return-12.22 %
1 Year Return+ 35.03 %
Previous Close₹29.10
Open₹28.80
Volume5.38L
Upper Circuit-
Lower Circuit-
Market Cap₹652.60Cr

Key Statistics

P/E Ratio126.52
PEG Ratio96.58
Market Cap₹652.60 Cr
P/B Ratio0.33
EPS-1.08

Company Information

Nectar Lifesciences Ltd (NLL or NECLIFE) is a globally acclaimed integrated pharmaceutical organization engaged in the manufacture and supply of high quality pharmaceutical products. With a vast network of production sites spread across three Indian states of Punjab, Himachal Pradesh, and Jammu, the organization provides top-notch active pharmaceutical ingredients (API), finished dosage forms, phytochemicals, and hard gelatin capsules to customers in over 90 countries across the world. In addition to manufacturing and marketing cephalosporins and phytochemicals, NECLIFE is also into contract manufacturing of APIs. Established in 1995, the organization has seen a number of expansions, the most recent being in 2019 when they established a unit in Portugal to take over marketing activities from the UK-based wing. They have also launched two new innovative products in the form of menthol capsules and pearl capsules. Focussing on providing quality products, NECLIFE has obtained approval from the Japanese MOH and is well-poised to continue its phenomenal rise in the global pharmaceuticals market.

Share Price: ₹28.59 per share as on 18 Jul, 2024 04:01 PM
Market Capitalisation: ₹652.60Cr as of today
Revenue: ₹439.85Cr as on March 2024 (Q1 24)
Net Profit: ₹0.59Cr as on March 2024 (Q1 24)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
OrganisationNectar Lifescience Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Nectar Lifescience Ltd

  • Nectar Lifesciences Shareholders See 85% Return in Last Year - 12 Jun, 2024

    Despite a decline in earnings over the last five years, Nectar Lifesciences has rewarded shareholders with an impressive total return of 85% in the past twelve months. The market's forward-looking nature is evident as the share price rose by 16% per year despite revenue shrinking by 13% annually.

  • Nectar Lifescience Q4 Net Sales Up 13.52% YoY - 20 May, 2024

    Nectar Lifescience's consolidated net sales for March 2024 stood at Rs. 441.37 crore, up 13.52% YoY. However, the quarterly net profit decreased by 83.9% YoY to Rs. 0.59 crore. The EPS also decreased from Rs. 0.16 in March 2023 to Rs. 0.03 in March 2024. Nectar Lifescience shares closed at Rs. 33.75 on May 17, 2024 (NSE) and have given returns of 19.47% over the last 6 months and 98.53% over the last 12 months.

  • Nectar Lifescience Q4 2024 Net Sales Up 13.52% - 17 May, 2024

    Nectar Lifescience's standalone net sales for March 2024 increased by 13.52% YoY, while quarterly net profit decreased by 88.83%. The company's EPS also decreased from Rs. 0.24 to Rs. 0.03 in the same period. However, Nectar Lifescience shares have given returns of 35.45% over the last six months and 98.26% over the last twelve months.

Insights on Nectar Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 21.63% to 21.91% in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 129.1% return, outperforming this stock by 156.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 96.8% return, outperforming this stock by 61.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.35% of holdings in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NECLIFE stock has moved down by -14.8%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.90% to 1.66% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 452.65 Cr → 442.84 Cr (in ₹), with an average decrease of 2.2% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.57 Cr → 0.59 Cr (in ₹), with an average decrease of 62.4% per quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹439.85Cr
↓2.72%
Net Income
₹0.59Cr
↓62.42%
Net Profit Margin
0.13%
↓62.86%
2023Y/Y Change
Revenue
₹1,523.67Cr
↓8.70%
Net Income
-₹24.18Cr
↓196.53%
Net Profit Margin
-1.59%
↓206.00%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹2,323.80Cr
↓7.80%
Total Liabilities
₹1,259.20Cr
↓12.16%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹133.37Cr
↑40.33%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
44.35%
0.00
Foreign Institutions
1.66%
-12.64
Mutual Funds
0%
0.00
Retail Investors
21.91%
1.33
Others
32.08%
-0.15

Key Indicators

Nectar Lifescience Ltd Valuation

Nectar Lifescience Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-284.58x)

December 21, 2023

Industry (56.76x)

July 16, 2024

Today (126.52x)

July 16, 2024

Highest (403.33x)

August 26, 2020

LowHigh

Earnings and Dividends

  • Nectar Lifescience Ltd Earnings Results

    Nectar Lifescience Ltd’s net profit fell -83.97% since last year same period to ₹0.59Cr in the Q4 2023-2024. On a quarterly growth basis, Nectar Lifescience Ltd has generated -62.42% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Nectar Lifescience Ltd Dividends July,2020

    In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.17%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Nectar Lifescience Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Nectar Lifescience Ltd shares.

Nectar Lifescience Ltd (NECLIFE) share price today is ₹28.59

Nectar Lifescience Ltd is listed on NSE

Nectar Lifescience Ltd is listed on BSE

  • Today’s highest price of Nectar Lifescience Ltd is ₹29.35.
  • Today’s lowest price of Nectar Lifescience Ltd is ₹28.49.

PE Ratio of Nectar Lifescience Ltd is 126.52

PE ratio = Nectar Lifescience Ltd Market price per share / Nectar Lifescience Ltd Earnings per share

Today’s traded volume of Nectar Lifescience Ltd(NECLIFE) is 5.38L.

Today’s market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹652.6Cr.

Nectar Lifescience Ltd(NECLIFEPrice
52 Week High
₹45.7
52 Week Low
₹21.25

Nectar Lifescience Ltd(NECLIFE) share price is ₹28.59. It is down -37.44% from its 52 Week High price of ₹45.7

Nectar Lifescience Ltd(NECLIFE) share price is ₹28.59. It is up 34.54% from its 52 Week Low price of ₹21.25

Nectar Lifescience Ltd(NECLIFEReturns
1 Day Returns
-0.51%
1 Month Returns
-14.79%
3 Month Returns
-12.22%
1 Year Returns
35.03%